ANIK — Anika Therapeutics Inc

Anika Therapeutics Inc (ANIK) is a drug manufacturers - specialty & generic company listed on NASDAQ. It is led by Cheryl Renee Blanchard Ph.D., based in 32 Wiggins Avenue, Bedford, MA, United States, 01730, with about 288 employees. Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management products include Monovisc and Orthovisc, an injectable HA-based viscosupplement for the pain relief from osteoarthritis conditions; and Cingal, a single-injection OA pain management product to provide short-and long-term pain relief. The company's joint preservation and restoration product family comprises orthopedic regenerative solutions, including Hyalofast and Tactoset; sports medicine solutions to repair and reconstruct damaged ligaments and tendons; and preserving joint solutions, including partial joint replacement, joint resurfacing, and invasive and bone sparing implants to treat upper and lower extremity orthopedic conditions. In addition, the company offers non-orthopedic products comprising HA-based products for Hyvisc, a molecular weight injectable HA veterinary product; Hyalobarrier, an anti-adhesion barrier for use after abdominal-pelvic surgeries; and Hyalomatrix for the treatment of burns and ulcers, as well as products used for the treatment of ears, nose and throat disorders, and ophthalmic. Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts.

Latest reported ANIK revenue for 2025-09-30 was $27.8M. Net income was -$2.3M. Revenue was down 1.4% from 2025-06-30 to 2025-09-30. ANIK currently screens at market cap $161.3M.

Use this ANIK page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ANIK quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ANIK SEC filings page. Lician reads the product cache first so this HTML stays unique to Anika Therapeutics Inc even when a live quote feed is slow.